{"schema_version":"secwatch.filing_event.v1","accession":"0001651308-22-000038","form_type":"8-K","ticker":"ONC","cik":"0001651308","company_name":"BeOne Medicines Ltd.","filed_at":"2022-03-03T23:59:59+00:00","discovered_at":"2026-05-14T18:04:07.579176+00:00","generated_at":"2026-06-27T02:01:54.309585+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"BeiGene CMO Hematology Jane Huang resigns; consulting agreement through Nov 2022","bullets":["Jane Huang, M.D., CMO Hematology, resigned effective April 3, 2022.","Consulting agreement runs from April 3 to November 14, 2022.","Unvested options/RSUs continue vesting until June 30, 2022; exercise period extended to 90 days after consulting ends.","No immediate replacement for CMO Hematology announced."],"urls":{"canonical":"https://secwatch.observer/filing/0001651308-22-000038","json":"https://secwatch.observer/filing/0001651308-22-000038.json","markdown":"https://secwatch.observer/filing/0001651308-22-000038.md","text":"https://secwatch.observer/filing/0001651308-22-000038.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1651308/000165130822000038/0001651308-22-000038-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1651308/000165130822000038/bgne-20220302.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-27T02:01:54.309585+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b65418954e","claim":"Jane Huang resigned as Chief Medical Officer, Hematology at BeOne Medicines Ltd..","evidence_excerpt":"On March 2, 2022, Jane Huang, M.D., Chief Medical Officer, Hematology of BeiGene, Ltd. (the “Company”), provided notice of her resignation from the Company effective April 3, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1651308/000165130822000038/0001651308-22-000038-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Chief Medical Officer, Hematology"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}